Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Summary of Recommendations
Recommendation Grading
Overview
Title
Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas
Authoring Organizations
Association for Molecular Pathology
College of American Pathologists
Publication Month/Year
February 16, 2022
Last Updated Month/Year
September 4, 2024
Supplemental Implementation Tools
Document Type
Guideline
Country of Publication
US
Document Objectives
To develop evidence-based recommendations for informing molecular biomarker testing for pediatric and adult patients with DGs and provide guidance for appropriate laboratory test and biomarker selection for optimal diagnosis, risk stratification, and prediction.
Inclusion Criteria
Male, Female, Adolescent, Adult, Child, Older adult
Health Care Settings
Ambulatory, Hospital, Laboratory services, Outpatient
Intended Users
Nurse, nurse practitioner, physician, physician assistant
Scope
Diagnosis, Assessment and screening
Diseases/Conditions (MeSH)
D005910 - Glioma, D015415 - Biomarkers, D014408 - Biomarkers, Tumor
Keywords
biomarkers, Molecular Biomarkers, brain cancer, Gliomas
Source Citation
Brat DJ, Aldape K, Bridge JA, Canoll P, Colman H, Hameed MR, Harris BT, Hattab EM, Huse JT, Jenkins RB, Lopez-Terrada DH, McDonald WC, Rodriguez FJ, Souter LH, Colasacco C, Thomas NE, Yount MH, van den Bent MJ, Perry A. Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. Arch Pathol Lab Med. 2022 Feb 17. doi: 10.5858/arpa.2021-0295-CP. Epub ahead of print. PMID: 35175291.